Phibro Animal Health Corporation (PAHC)

Receivables turnover

		Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Revenue (ttm)	US$ in thousands	993,816	966,848	952,851	955,955	960,113	955,995	953,390	945,191	935,602	907,274	879,384	852,821	833,350	798,955	797,965	805,828	800,354	818,354	813,351	817,562
Receivables	US$ in thousands	169,452	161,087	150,627	149,228	163,479	152,740	151,830	142,728	166,537	156,561	142,495	140,644	146,852	135,562	126,026	125,457	126,522	151,556	147,441	145,444
Receivables turnover		5.86	6.00	6.33	6.41	5.87	6.26	6.28	6.62	5.62	5.80	6.17	6.06	5.67	5.89	6.33	6.42	6.33	5.40	5.52	5.62

June 30, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $993,816K ÷ $169,452K
= 5.86

The receivables turnover ratio for Phibro Animal Health Corporation has fluctuated over the past few quarters, ranging from 5.40 to 6.62. This ratio measures how efficiently the company is collecting payments from its customers. A higher turnover ratio indicates that the company is collecting its accounts receivable more quickly.

Overall, Phibro Animal Health Corporation has maintained a relatively stable receivables turnover ratio, staying within the range of 5.40 to 6.62. This consistency suggests that the company has been effective in managing its accounts receivable over the analyzed period. However, it is important for the company to monitor and potentially improve this ratio further to ensure timely cash inflows and efficient working capital management.